NCL Technology Ventures

Venture Capital Active United Kingdom
Last updated 2026-06-18
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$6.0M
total disclosed, rounds participated
Stages
—

Portfolio · 1

Curesponse
Personalized Medicine for Accurate Cancer Treatment
1 round $6.0M committed Latest: 2020-06

Investment activity

Portfolio by sector

Health Tech & Life Sciences1

Q&A

What is NCL Technology Ventures' primary investment focus?
NCL Technology Ventures has invested in the Health Tech & Life Sciences sector, with one portfolio company in this area.
Can you name a notable company in NCL Technology Ventures' portfolio?
Curesponse, a company focused on personalized medicine for cancer treatment, is a notable company in NCL Technology Ventures' portfolio.
What was the funding stage and amount for NCL Technology Ventures' investment in Curesponse?
NCL Technology Ventures participated in Curesponse's Series A round, which raised $14M.
When did NCL Technology Ventures make its investment in Curesponse?
NCL Technology Ventures made an investment in Curesponse in June 2020.
What is the typical investment range for NCL Technology Ventures?
NCL Technology Ventures' investment range is $6M - $6M.
What stage of funding does NCL Technology Ventures typically participate in?
NCL Technology Ventures has participated in A Round funding stages.